Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $334.21M | $498.90M | 26.13% | +$164.69M |
| Ocular Therapeutix, Inc.(OCUL) | 12,762,462 | 12,762,462 | 0 | $87.30M | $111.03M | 5.82% | +$23.74M |
| Enliven Therapeutics Inc | 4,026,331 | 4,026,331 | 0 | $94.10M | $102.83M | 5.39% | +$8.74M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,671 | 3,882,709 | +38 | $50.51M | $88.33M | 4.63% | +$37.82M |
| Applied Therapeutics Inc | 9,542,871 | 9,825,000 | +282,129 | $44.57M | $83.51M | 4.37% | +$38.95M |
| Spyre Therapeutics, Inc.(SYRE) | 2,685,448 | 2,685,448 | 0 | $63.13M | $78.98M | 4.14% | +$15.84M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $76.72M | $78.09M | 4.09% | +$1.37M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 3,085,620 | +3,085,620 | $0 | $75.63M | 3.96% | +$75.63M |
| Kalvista Pharmaceuticals Inc | 6,249,731 | 6,249,731 | 0 | $73.62M | $72.37M | 3.79% | -$1.25M |
| Pharvaris N V COM | 3,395,606 | 3,395,606 | 0 | $63.84M | $62.89M | 3.29% | -$950.8K |
| Cogent Biosciences, Inc.(COGT) | 5,684,167 | 5,684,167 | 0 | $47.92M | $61.39M | 3.22% | +$13.47M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,094,373 | 1,744,373 | -350,000 | $54.20M | $47.76M | 2.50% | -$6.44M |
| 4d Molecular Therapeutics In | 4,400,000 | 4,400,000 | 0 | $92.36M | $47.56M | 2.49% | -$44.79M |
| Merus N V | 1,263,214 | 907,963 | -355,251 | $74.74M | $45.36M | 2.38% | -$29.38M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,394,527 | 4,394,527 | 0 | $31.07M | $45.04M | 2.36% | +$13.97M |
| Erasca, Inc.(ERAS) | 16,216,216 | 16,216,216 | 0 | $38.27M | $44.27M | 2.32% | +$6.00M |
| Praxis Precision Medicines, Inc.(PRAX) | 706,131 | 706,131 | 0 | $29.21M | $40.63M | 2.13% | +$11.43M |
| Astria Therapeutics Inc | 3,608,645 | 3,458,645 | -150,000 | $32.84M | $38.08M | 1.99% | +$5.24M |
| Terns Pharmaceuticals Inc | 3,410,058 | 3,410,058 | 0 | $23.22M | $28.44M | 1.49% | +$5.22M |
| Aquestive Therapeutics Inc | 5,555,555 | 5,555,555 | 0 | $14.44M | $27.67M | 1.45% | +$13.22M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,818,182 | 1,000,000 | -818,182 | $32.75M | $26.69M | 1.40% | -$6.06M |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 1,609,569 | +1,609,569 | $0 | $24.87M | 1.30% | +$24.87M |
| Engene Holdings Inc COM | 2,825,983 | 3,565,841 | +739,858 | $26.65M | $23.53M | 1.23% | -$3.11M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,379,965 | 1,379,965 | 0 | $24.07M | $23.10M | 1.21% | -$966.0K |
| Mersana Therapeutics Inc | 11,328,000 | 11,328,000 | 0 | $22.77M | $21.41M | 1.12% | -$1.36M |
| Taysha Gene Therapies, Inc.(TSHA) | 9,000,000 | 9,000,000 | 0 | $20.16M | $18.09M | 0.95% | -$2.07M |
| ABIVAX Société AnonymeADS(ABVX) | 1,345,780 | 1,345,780 | 0 | $17.79M | $15.50M | 0.81% | -$2.29M |
| Trevi Therapeutics, Inc.(TRVI) | 3,422,637 | 3,422,656 | +19 | $10.20M | $11.43M | 0.60% | +$1.23M |
| Arvinas, Inc.(ARVN) | 627,788 | 454,450 | -173,338 | $16.71M | $11.19M | 0.59% | -$5.52M |
| Adverum Biotechnologies Inc | 1,467,048 | 1,467,048 | 0 | $10.06M | $10.30M | 0.54% | +$234.7K |
| Century Therapeutics, Inc.(IPSC) | 5,389,259 | 5,389,259 | 0 | $13.74M | $9.22M | 0.48% | -$4.53M |
| Zura Bio LimitedCL A(ZURA) | 6,023,166 | 2,023,166 | -4,000,000 | $21.08M | $8.21M | 0.43% | -$12.87M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.54M | $7.51M | 0.39% | -$30.0K |
| Cabaletta Bio, Inc.(CABA) | 1,563,952 | 1,563,952 | 0 | $11.70M | $7.38M | 0.39% | -$4.32M |
| CASI Pharmaceuticals, Inc.(CASIF) | 111,686 | 987,259 | +875,573 | $614.3K | $6.08M | 0.32% | +$5.47M |
| Tenaya Therapeutics, Inc.(TNYA) | 1,555,556 | 1,555,556 | 0 | $4.82M | $3.00M | 0.16% | -$1.82M |
| Instil Bio, Inc.(TIL) | 0 | 33,177 | +33,177 | $0 | $2.23M | 0.12% | +$2.23M |
| Tenax Therapeutics, Inc.(TENX) | 0 | 208,333 | +208,333 | $0 | $720.8K | 0.04% | +$720.8K |
| Arca Biopharma Inc | 866,375 | 0 | -866,375 | $3.32M | $0 | — | -$3.32M |